Archives of General Psychiatry · 1984 · 42 citations · 33 references
MedicinePharmacologyPsychiatryNeuropharmacologyPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyDopaminergic PharmacologyNeuropsychiatric PharmacotherapySchizophrenia PharmacotherapyAntipsychotic-induced Tardive DyskinesiaAtypical Antipsychotic TreatmentDopamine PharmacodynamicsPsychostimulant PharmacotherapyTardive Dyskinesia Treatment
Previous studies have variably reported the efficacy of apomorphine in treatment of schizophrenia and tardive dyskinesia. Stimulation of dopamine neuron autoreceptors is the presumed mode of action. Low-dose apomorphine (0.75 mg subcutaneously) and placebo were administered to 25 male schizophrenics to evaluate the drug's effect on psychotic and tardive dyskinetic symptoms. No significant improvement or deterioration was seen. Concomitant measurements of plasma prolactin and growth hormone levels and CSF homovanillic acid level indicated that the dose used was centrally active. These results indicate that an active though nonsedating dose of apomorphine does not ameliorate symptoms of schizophrenia or tardive dyskinesia.
33
The Brief Psychiatric Rating Scale
John E. Overall, Donald R. Gorham · Psychological Reports · 1962 · 10.9K citations
Diagnostic Criteria for Use in Psychiatric Research
John P. Feighner · Archives of General Psychiatry · 1972 · 5.7K citations
Jean Endicott · Archives of General Psychiatry · 1978 · 5.7K citations
Dementia Praecox or the Group of Schizophrenias
Eugen Bleuler · Journal of the American Medical Association · 1951 · 4.4K citations · Full text
Medicine, Neurology, Psychiatry +10